30118774|t|Neuroprotective effects of bergenin in Alzheimer's disease: Investigation through molecular docking, in vitro and in vivo studies.
30118774|a|Alzheimer's disease (AD) is an enervating and chronic progressive neurodegenerative disorder, occurring frequently in the elderly and adversely affecting intellectual capabilities and the cognitive processes. Bergenin possesses efficacious antioxidant, antiulcerogenic, anti-HIV, hepatoprotective, neuroprotective, anti-inflammatory and immunomodulatory activity along with antinociceptive effect and wound healing properties. Previous studies have shown that bergenin has in vitro bovine adrenal tyrosine hydroxylase inhibitory activity, mushroom tyrosinase inhibitory activities, beta-secretase (BACE-1) enzyme inhibitory activity and prevented neuronal death in the primary culture of rat cortical neurons. Protein tyrosine phosphatase-1B (PTP1B) is an intriguing target for anticancer and antidiabetic drugs and has recently been implicated to act as a positive regulator of neuroinflammation. Bergenin is also found to inhibit human protein tyrosine phosphatase-1B (hPTP1B) in vitro. Thus, bergenin was screened by molecular docking study using GOLD suite (version 5.2), CCDC for predicting its activity against targets of AD management like acetylcholinesterase (AChE) (1B41), butyrylcholinesterase (BuChE) (1P0I), Tau protein kinase 1 (GSK-3beta) (1J1B), BACE-1 (1FKN) wherein the GOLD score and fitness of bergenin were comparable to those of standard drugs like donepezil, galanthamine, physostigmine, etc. Bergenin demonstrated dose-dependent inhibition of both AChE and BuChE in vitro and found to be safe up to 50 muM when screened in vitro on SH-SY5Y cell lines by cytotoxicity studies using MTT and Alamar blue assays. It also led to dose-dependent prevention of NMDA induced toxicity in these cells. Pretreatment with bergenin (14 days) in rats at three dose levels (20, 40 and 80 mg/kg; p.o.) significantly (p < 0.01) and dose-dependently alleviated amnesia induced by scopolamine (2 mg/kg, i.p.). The therapeutic effect of bergenin supplementation for 28 days, at three dose levels, was also evaluated in streptozotocin (3 mg/kg, ICV, unilateral) induced AD model in Wistar rats using Morris water maze and Y maze on 7th, 14th, 21st and 28th days. STZ caused significant (p < 0.001) cognitive impairment and cholinergic deficit and increased oxidative stress in rats. Bergenin could significantly ameliorate STZ induced behavioral deficits, inhibit the AChE and BuChE activity in parallel with an increase in the diminished GSH levels in a dose-dependent fashion. The histopathological investigations were also supportive of this datum. The bergenin treatment at 80 mg/kg led to significant (p < 0.05) abatement of the raised Abeta-1-42 levels and alleviated the perturbed p- tau levels leading to significantly low (p < 0.01) levels of p-tau in brain homogenates of rats as compared to ICV STZ injected rats. In conclusion, the observed effects might be attributed to the cholinesterase inhibitory activity of bergenin coupled with its antioxidant effect, anti-inflammatory activity and reduction of Abeta-1-42 and p-tau levels which could have collectively helped in the attenuation of cognitive deficits. The current findings of the study are indicative of the promising preventive and ameliorative potential of bergenin in the management of AD through multiple targets.
30118774	27	35	bergenin	Chemical	MESH:C006741
30118774	39	58	Alzheimer's disease	Disease	MESH:D000544
30118774	131	150	Alzheimer's disease	Disease	MESH:D000544
30118774	152	154	AD	Disease	MESH:D000544
30118774	197	223	neurodegenerative disorder	Disease	MESH:D019636
30118774	340	348	Bergenin	Chemical	MESH:C006741
30118774	406	409	HIV	Disease	MESH:D015658
30118774	451	463	inflammatory	Disease	MESH:D007249
30118774	591	599	bergenin	Chemical	MESH:C006741
30118774	613	627	bovine adrenal	Species	
30118774	628	648	tyrosine hydroxylase	Gene	280707
30118774	670	689	mushroom tyrosinase	Species	
30118774	729	735	BACE-1	Gene	29392
30118774	778	792	neuronal death	Disease	MESH:D009410
30118774	819	822	rat	Species	10116
30118774	841	872	Protein tyrosine phosphatase-1B	Gene	5770
30118774	874	879	PTP1B	Gene	5770
30118774	1010	1027	neuroinflammation	Disease	MESH:D000090862
30118774	1029	1037	Bergenin	Chemical	MESH:C006741
30118774	1063	1068	human	Species	9606
30118774	1069	1100	protein tyrosine phosphatase-1B	Gene	5770
30118774	1126	1134	bergenin	Chemical	MESH:C006741
30118774	1259	1261	AD	Disease	MESH:D000544
30118774	1278	1298	acetylcholinesterase	Gene	43
30118774	1300	1304	AChE	Gene	43
30118774	1307	1311	1B41	Chemical	-
30118774	1314	1335	butyrylcholinesterase	Gene	590
30118774	1337	1342	BuChE	Gene	590
30118774	1374	1383	GSK-3beta	Gene	2932
30118774	1393	1399	BACE-1	Gene	23621
30118774	1445	1453	bergenin	Chemical	MESH:C006741
30118774	1502	1511	donepezil	Chemical	MESH:D000077265
30118774	1513	1525	galanthamine	Chemical	MESH:D005702
30118774	1527	1540	physostigmine	Chemical	MESH:D010830
30118774	1547	1555	Bergenin	Chemical	MESH:C006741
30118774	1603	1607	AChE	Gene	43
30118774	1612	1617	BuChE	Gene	590
30118774	1687	1694	SH-SY5Y	CellLine	CVCL:0019
30118774	1709	1721	cytotoxicity	Disease	MESH:D064420
30118774	1736	1739	MTT	Chemical	MESH:C070243
30118774	1744	1755	Alamar blue	Chemical	MESH:C005843
30118774	1808	1812	NMDA	Chemical	MESH:D016202
30118774	1821	1829	toxicity	Disease	MESH:D064420
30118774	1864	1872	bergenin	Chemical	MESH:C006741
30118774	1886	1890	rats	Species	10116
30118774	1997	2004	amnesia	Disease	MESH:D000647
30118774	2016	2027	scopolamine	Chemical	MESH:D012601
30118774	2071	2079	bergenin	Chemical	MESH:C006741
30118774	2153	2167	streptozotocin	Chemical	MESH:D013311
30118774	2203	2205	AD	Disease	MESH:D000544
30118774	2222	2226	rats	Species	10116
30118774	2296	2299	STZ	Chemical	MESH:D013311
30118774	2331	2351	cognitive impairment	Disease	MESH:D003072
30118774	2356	2375	cholinergic deficit	Disease	MESH:C535672
30118774	2410	2414	rats	Species	10116
30118774	2416	2424	Bergenin	Chemical	MESH:C006741
30118774	2456	2459	STZ	Chemical	MESH:D013311
30118774	2468	2487	behavioral deficits	Disease	MESH:D019958
30118774	2501	2505	AChE	Gene	83817
30118774	2510	2515	BuChE	Gene	590
30118774	2572	2575	GSH	Chemical	MESH:D005978
30118774	2689	2697	bergenin	Chemical	MESH:C006741
30118774	2821	2827	p- tau	Gene	29477
30118774	2885	2890	p-tau	Gene	29477
30118774	2915	2919	rats	Species	10116
30118774	2939	2942	STZ	Chemical	MESH:D013311
30118774	2952	2956	rats	Species	10116
30118774	3021	3035	cholinesterase	Gene	65036
30118774	3059	3067	bergenin	Chemical	MESH:C006741
30118774	3110	3122	inflammatory	Disease	MESH:D007249
30118774	3164	3169	p-tau	Gene	29477
30118774	3236	3254	cognitive deficits	Disease	MESH:D003072
30118774	3363	3371	bergenin	Chemical	MESH:C006741
30118774	3393	3395	AD	Disease	MESH:D000544
30118774	Association	MESH:D000544	29477
30118774	Association	MESH:D000544	23621
30118774	Negative_Correlation	MESH:C006741	43
30118774	Negative_Correlation	MESH:C006741	29392
30118774	Association	MESH:D005978	29477
30118774	Association	MESH:D019958	29477
30118774	Association	MESH:D000544	590
30118774	Association	MESH:D000544	43
30118774	Association	65036	83817
30118774	Association	MESH:D019958	83817
30118774	Association	MESH:C535672	65036
30118774	Cotreatment	MESH:C006741	MESH:D010830
30118774	Association	MESH:D003072	83817
30118774	Association	MESH:C006741	2932
30118774	Association	MESH:C006741	29477
30118774	Association	MESH:D005978	83817
30118774	Positive_Correlation	MESH:D012601	MESH:D000647
30118774	Negative_Correlation	MESH:C006741	MESH:D000544
30118774	Negative_Correlation	MESH:C006741	65036
30118774	Association	MESH:D005978	MESH:D019958
30118774	Association	MESH:C535672	83817
30118774	Negative_Correlation	MESH:C006741	MESH:D009410
30118774	Association	MESH:D000544	2932
30118774	Association	MESH:D019958	65036
30118774	Negative_Correlation	MESH:C006741	MESH:D019958
30118774	Positive_Correlation	MESH:D016202	MESH:D064420
30118774	Negative_Correlation	MESH:C006741	83817
30118774	Association	29477	83817
30118774	Association	MESH:D003072	65036
30118774	Association	MESH:D000090862	5770
30118774	Association	29477	65036
30118774	Association	MESH:D000544	83817
30118774	Negative_Correlation	MESH:C006741	MESH:D003072
30118774	Cotreatment	MESH:C006741	MESH:D005702
30118774	Cotreatment	MESH:C006741	MESH:D000077265
30118774	Negative_Correlation	MESH:C006741	MESH:D016202
30118774	Negative_Correlation	MESH:C006741	MESH:D012601
30118774	Association	MESH:D003072	29477
30118774	Negative_Correlation	MESH:C006741	MESH:D015658
30118774	Association	MESH:D000544	65036
30118774	Negative_Correlation	MESH:C006741	5770
30118774	Association	MESH:D005978	65036
30118774	Association	MESH:C535672	29477
30118774	Negative_Correlation	MESH:C006741	MESH:D007249
30118774	Negative_Correlation	MESH:C006741	MESH:C535672
30118774	Negative_Correlation	MESH:D000077265	MESH:D000544
30118774	Negative_Correlation	MESH:C006741	23621
30118774	Negative_Correlation	MESH:C006741	280707
30118774	Negative_Correlation	MESH:C006741	590
30118774	Negative_Correlation	MESH:C006741	MESH:D000647
30118774	Association	MESH:D005978	MESH:C535672

